- Report
- December 2025
- 284 Pages
Global
From €5195EUR$5,850USD£4,539GBP
- Report
- November 2025
- 184 Pages
Global
From €3148EUR$3,545USD£2,750GBP
€3498EUR$3,939USD£3,056GBP
- Report
- September 2025
- 250 Pages
Global
From €3988EUR$4,490USD£3,483GBP
- Report
- December 2025
- 471 Pages
Global
From €5195EUR$5,850USD£4,539GBP
- Report
- June 2025
- 200 Pages
Global
From €2477EUR$2,789USD£2,164GBP
- Report
- April 2023
- 117 Pages
Global
From €4218EUR$4,750USD£3,685GBP
- Report
- September 2024
- 188 Pages
Global
From €3996EUR$4,500USD£3,491GBP
- Report
- January 2024
- 103 Pages
Global
From €3500EUR$4,222USD£3,165GBP
- Report
- December 2025
- 50 Pages
Global
From €2353EUR$2,650USD£2,056GBP
- Report
- December 2025
- 50 Pages
Global
From €2353EUR$2,650USD£2,056GBP
- Report
- December 2025
- 50 Pages
Global
From €2353EUR$2,650USD£2,056GBP
- Report
- December 2025
- 50 Pages
Global
From €2353EUR$2,650USD£2,056GBP

Hydroxyzine is a medication used to treat mental disorders, such as anxiety, tension, and agitation. It is a sedative-hypnotic drug, meaning it has a calming effect on the central nervous system. It is also used to treat nausea, vomiting, and itching. Hydroxyzine is available in both oral and injectable forms. It is generally well-tolerated, with few side effects.
Hydroxyzine is used to treat a variety of mental disorders, including anxiety, panic disorder, obsessive-compulsive disorder, post-traumatic stress disorder, and bipolar disorder. It is also used to treat insomnia, as well as nausea and vomiting associated with chemotherapy.
Hydroxyzine is a popular choice for treating mental disorders due to its effectiveness and low risk of side effects. It is available in generic and brand-name forms, and is often prescribed in combination with other medications.
Some companies in the Hydroxyzine market include Pfizer, Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more